Pharma Focus Asia
Klöckner Pentaplast - Pentapharm® alfoil® films

Novel Plasma Technology Developed to Treat Multidrug Refractory Bacteria

Plasmology4® has developed a revolutionary, advanced, and specialised form of ‘non-thermal’ or ‘cold plasma’technology called ‘Plaz4®’.

Plasmology4® is harnessing the 4th state of matter i.e. plasma, to improve the quality of patients' lives worldwide. Plaz4 is designed to treat the multidrug-refractory bacterial and/or fungal pathogen bioburden in a wound bed.

Plaz4 has the potential to destroy microbial cells including bacteria, fungi, and multidrug-resistant pathogens without harming the skin and soft tissues and has manyhealthcare applications, including the prevention and treatment of infections.By combining high voltage electricity with a non-combustible gas, glowing gas plasma is generated and delivered to wound tissues where it destroys pathogens. Plaz4®, while highly energized,is completely cool to the touch and cannot heat up tissues.

Besides, the results from initial pre-clinical studies of the plasma technology have shown a considerable decrease in antibiotic-resistant bacteria (MRSA) in a single topical treatment.

magazine-slider-imageBIOVIA from Molecule to MedicineMFA + MMA 2024CPHI China || PMEC China 2024Asia Healthcare Week 2024Advance DoE WorkshopCPHI Korea 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinRehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference3rd World ADC Asia 2024LogiPharma Asia 2024